Increased Cyclin Dependent Kinase in Aortic Tissue of Rats Fed Homocysteine

Summary

Background. Hyperhomocyst(e)inemia is strongly associated with occlusive arterial disease. Several mechanisms for the development of vascular lesions have been described. A direct effect of homocysteine on proliferation of smooth muscle cells and collagen expression was proposed recently. These observations led us to examine the effect of homocysteine on cyclin dependent kinase, the starter of mitosis and reflecting proliferation.

Methods and results. Thirty Him: OF A rats were divided into three groups. Ten animals were fed for a period of six weeks 50 mg/kg body wt per day homocysteine, ten the same dose of homocysteic acid and ten remained untreated controls. At the end of the experiment we determined aortic cyclin dependent kinase, phosphokinases A and C, aortic homocyst(e)ine and aortic hydroxyproline. Aortic cyclin dependent kinase was significantly (p = 0.0001) elevated in the homocysteine treated group (mean 120 ± 15) compared with the homocysteic acid treated group (mean 71 ± 11) or the untreated group (mean 72 ± 10 fmol/mg aortic tissue). Aortic homocyst(e)ine was significantly higher in homocysteine treated animals (p = 0.0002) strongly correlating with cyclin dependent kinase (r squared = 0.85, p = 0.0001) and with aortic hydroxyproline (r squared = 0.66, p = 0.0001), which in turn was significantly (p = 0.0001) increased in the homocysteine treated group. Phosphokinases A and C determined to rule out nonspecific effects on kinases were not increased by administered homocysteine.

Conclusions. Our findings indicate that homocysteine stimulates aortic cyclin dependent kinase with the possible consequence of proliferation of aortic cells. Aortic collagen accumulation could be explained by either the homocysteine-effect on collagen synthesis described in literature, or secondarily, by increased proliferation of collagen producing aortic cells.

• References

• 1 Brattstrom LE, Hardebo JE, Hultberg BL. Moderate homocysteinemia - A possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15: 1012-1016
• 2 Boers GHJ, Smals AG, Trijbels FJ. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 316: 725-730
• 3 Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Circulation 1989; 79: 1180-1188
• 4 Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, De Garmo P. Elevated plasma homocyst(e)ine in acute stroke and TIA: A possible risk factor for stroke. Stroke 1990; 21: 572-576
• 5 Clarke R, Kaly L, Robinson K, Naughten E, Calahane S, Fowler B, Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155
• 6 Brattstrom LE, Lindgren A, Israelsson B, Malinow MR, Norrving B, Upson B, Hamerfeldt A. Hyperhomocysteinemia in stroke - Prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992; 22: 214-221
• 7 Crawford DW, Blankenhorn DH. Arterial wall oxygenation, oxyradicals and atherosclerosis. Atherosclerosis 1991; 89: 97-108
• 8 Starkebaum G, Harlan JM. Endothelial cell injury due to copper catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986; 77: 1370-1376
• 9 Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Single D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelial-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308-318
• 10 Frauscher G, Karnaukhova E, Muehl A, Hoeger H, Lubec B. Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid - Additional mechanisms in homocysteine induced endothelial damage?. Life Sci 1995; 57: 813-817
• 11 Mao Y, Lubec G, Getoff N, Solar S, Quint RM. The effect of homocysteine thiolactone and its alpha-alkylated derivatives on the survival of irradiated E. coli AB1157. Rad Phys Chem 1994; 44: 473-478
• 12 Lubec B, Szekeres Th. Growth promotion by homocysteine thiolactone and its alpha-alkylated derivative. Amino Acids 1994; 7: 109-111
• 13 Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee M. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91: 6369-6373
• 14 Doree M, Galas S. The cyclin dependent protein kinases and the control of cell division. FASEB J 1994; 8: 1114-1121
• 15 Fermo I, Arcelloni E, De Vecchi S, Vigano S, Paroni R. High performance liquid chromatography method with fluorescence detection for the determination of total homocyst(e)ine in plasma. J Chromatogr 1992; 593: 171-176
• 16 Khaidar A, Marx M, Lubec B, Lubec G. L-arginine reduces heart collagen accumulation in the diabetic db/db mouse. Circulation 1994; 90: 479-483
• 17 Woessner JF. Determination of hydroxyproline in tissue and protein sample containing small proportion of this amino acid. Arch Biochem Biophys 1961; 93: 440-447
• 18 Draetta G, Beach D, Moran E. Synthesis of p34, the mammalian homolog of the yeast cdc2sup<blank>+CDC28 protein kinase, is stimulated during adenovirus induced proliferation of primary baby rat kidney cells. Oncogene 1988; 6: 553-557
• 19 Labbe JC, Lee MG, Nurse P, Picard A, Doree M. Activation at M-phase of a protein kinase encoded by a starfish homologue of the cell cycle control gene cdc2sup<blank>+. Nature 1988; 335: 251-254
• 20 Riabowol K, Draetta G, Brizuela L, Vandre D, Beach D. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 1989; 57: 393-401
• 21 McGowan CH, Russell P, Reed SI. Periodic biosynthesis of the human M-phase promoting factor catalytic subunit p34 during the cell cycle. Mol Cell Biol 1990; 10: 3847-3851
• 22 Lucas JJ, Terada N, Szepesi A, Gelfand EW. Regulation of synthesis of p34(cdc2) and its homologues and their relationship to pllO(Rb) phosphorylation during cell cycle progression of normal human T cells. J Immunol 1992; 148: 1804-1811
• 23 Dutta A, Stillman B. Cdc2 family kinases phosphorylate a human cell DNA replication factor, RPA and activate DNA replication. EMBO J 1992; 11: 2189-2199
• 24 Stern H. Sulphhydryl groups and cell division. Science 1956; 124: 1292-1233
• 25 Mazia D. Biochemistry of the dividing cell. Ann Rev Biochem 1961; 30: 669-688
• 26 Majors AK, Erhard LA, Bezacka EH. A link between homocysteinemia and atherosclerosis: Enhanced collagen synthesis and accumulation by arterial smooth muscle cells exposed to homocysteine. Irish J Med Sci 1995 164. 15 (abstract)
• 27 Shiekhattar R, Mermelstein F, Fisher RP, Drapkin R, Dynlacht B, Wessling HC, Morgan DO, Reinberg D. Cdk activating kinase complex is a component of human transcription factor TFIIH. Nature 1995; 374: 283-287
• 28 Zhou W, Takuwa N, Kumada M, Takuwa Y. E2F1, B-myb and selective members of the cyclin/cdk subunits are targets for protein kinase C mediated bimodal growth regulation in vascular endothelial cells. Biochem Biophys Res Comm 1994; 199: 191-198
• 29 Reed SI, Bailly E, Dulic V, Hengst L, Resnitzky D, Lingerland J. GI control in mammalian cells. J Cell Sci 1994; 18: 69-73